Status
Conditions
Treatments
About
Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined.
In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.
Full description
Aim 1: determine whether acute exposure to stress (increasing sympathetic nervous system activation) increases plasma amyloid-beta-40 and amyloid-beta-42 in the five hours following exposure.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
- Unwilling to be filmed during the stress task OR unwilling to sign the waiver allowing their filmed responses to be used in scientific presentations
Primary purpose
Allocation
Interventional model
Masking
38 participants in 2 patient groups
Loading...
Central trial contact
Lab Manager
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal